CWG
LENZ

C WorldWide Group’s LENZ Therapeutics LENZ Stock Holding History

C WorldWide Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.41M Buy
700,000
+200,000
+40% +$2.81M 0.14% 66
2025
Q4 		$8M Buy
+500,000
New +$14.6M 0.14% 67

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

C WorldWide Group's LENZ Position: Q1 2026 in Review

C WorldWide Group increased its LENZ Therapeutics (LENZ) stake by 40% in Q1 2026, buying an estimated $2.81M and bringing the position to 700,000 shares worth $6.41M. The position accounts for 0.14% of the portfolio, ranked #66.

C WorldWide Group first reported a position in LENZ in Q4 2025 and has held it in 2 quarters since. The position peaked at $8M in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • C WorldWide Group held 700,000 shares of LENZ Therapeutics worth $6.41M as of Q1 2026.
  • C WorldWide Group bought 200,000 LENZ Therapeutics shares in Q1 2026, an estimated $2.81M.
  • LENZ Therapeutics made up 0.14% of C WorldWide Group's portfolio in Q1 2026, its #66 holding.
  • C WorldWide Group first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • C WorldWide Group's LENZ Therapeutics position peaked at $8M in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on C WorldWide Group's 13F filing for Q1 2026, filed 6 May 2026.